The House and Senate are considering legislation to speed entry of generic competition into the market as a means to provide greater patient access and lower prescription costs for consumers.  The Senate and the House coalition letter are available online.  Simply put, what the CREATES Act represents is a market-based way that contributes to giving consumers access to lower cost prescription drugs without stifling innovation. This legislation are similar efforts take necessary steps to address the affordability and accessibility of prescription drugs.